Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110256211B reveals a photoredox method for 1,1-diarylalkane derivatives. Offers mild conditions and cost reduction in fine chemical manufacturing for global supply chains.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN103333049A reveals a recyclable phosphotungstic acid ionic liquid catalyst for styrene oxide alcoholysis, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Patent CN110003299A details a novel THF-based synthesis for Betamethasone intermediates offering higher purity and reduced toxicity for reliable pharmaceutical supply chains.
Patent CN114276251A reveals a mild Lewis acid-catalyzed nitration method. Achieve high-purity nitroarenes with reduced waste and superior selectivity for API manufacturing.
Novel method for directional acyl migration using sulfonic acid. Enhances purity and reduces costs for API intermediate manufacturing with mild conditions.
Patent CN109748883B details a metal-free asymmetric ring-opening method for high-purity chiral beta-amino derivatives, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN103145574A reveals a cost-effective Diclofenac route using N-chloroamide cyclization. Ideal for reliable pharmaceutical intermediates supplier seeking scalable API manufacturing.
Novel room-temperature method using metal triflates. High yield, recyclable catalyst, green solvents. Ideal for pharma intermediates.
Patent CN110105362B details a safe, high-yield folic acid synthesis using heteropoly acid catalysts, eliminating hazardous chlorination for reliable API intermediate supply.
Patent CN103288757A reveals a novel solid-acid catalyzed nitration route for key TKI intermediates, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturers.
Novel synthesis method for azacycle-derived polyarylmethane antitumor compounds offering mild conditions and high cytotoxic activity for pharmaceutical supply chains.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Offers mild conditions and high enantioselectivity for reliable supply chain integration.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis method for N-N axis chiral compounds offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis. Enables cost reduction and supply chain reliability for anticancer intermediates.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Patent CN116768904B reveals high-yield chiral synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Novel metal-free route for spiro-chroman-4,3'-oxindole using 2,5-dimethylfuran. Enhances supply chain reliability and reduces heavy metal contamination risks.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.